Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MGB Biopharma Ltd.
DescriptionIV formulation of an antibiotic that binds the minor groove of bacterial DNA
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationGram-positive bacterial infection
Indication DetailsTreat Gram-positive hospital acquired infections
Regulatory Designation U.S. - Qualified Infectious Disease Program (Treat Gram-positive hospital acquired infections)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today